Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
RenaMed Biologics
About
RenaMed Biologics engages in the development of therapies for the treatment of diseases associated with compromised kidney function.
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $40M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 1995
- Operating Status
- Active
RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function. The company focuses on patients suffering from acute renal failure and additional indications where kidney function is compromised. It develops RBI-01, which utilizes physiologically active human renal epithelial cells and administered ex vivo, to replace and maintain severely compromised, or lost kidney functions due to illness, or trauma. The company was founded in 1995 as Nephros Therapeutics, Inc. and changed its name to RenaMed Biologics, Inc. in 2005. RenaMed Biologics, Inc. is based in Lincoln, Rhode Island.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 7, 2006 | Series Unknown | $40M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
TSC BioVenture Capital Corporation
|
— | Series Unknown |
